PVI
RGEN icon

Pura Vida Investments’s Repligen RGEN Stock Holding History

Pura Vida Investments’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,800
Closed -$3.35M – 151
2022
Q4 		$3.35M Sell
19,800
-10,200
-34% -$1.85M 0.17% 104
2022
Q3 		$5.61M Buy
30,000
+5,000
+20% +$1.05M 0.32% 77
2022
Q2 		$4.06M Buy
+25,000
New +$3.95M 0.24% 99
2021
Q4 		– Sell
-12,500
Closed -$3.61M – 297
2021
Q3 		$3.61M Buy
+12,500
New +$3.21M 0.11% 165

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Pura Vida Investments's RGEN Position: Q2 2024 in Review

Pura Vida Investments sold out of Repligen (RGEN) in Q2 2024, closing a stake of 11,225 shares — an estimated $2.06M sold.

Pura Vida Investments first reported a position in RGEN in Q4 2020 and held it in 4 quarters. The position peaked at $4.79M in Q4 2020. 454 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Pura Vida Investments reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 11,225 Repligen shares in Q2 2024, an estimated $2.06M.
  • Pura Vida Investments first reported a position in Repligen in Q4 2020 and held it in 4 quarters.
  • Pura Vida Investments's Repligen position peaked at $4.79M in Q4 2020.
  • 454 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.